FDA approves Escalon subsidiary's hematology device

12/18/2007 | Reuters

The FDA has granted Escalon Medical Corp.'s Drew Scientific unit approval to market its D3 Hematology System, an automatic three-part differential hematology analyzer. The device should reach the market in the U.S. before the end of the year, Escalon said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC